Hormone (Endocrine) Therapy for Cancer in Melbourne
Hormone therapy, also called endocrine therapy, is a systemic cancer treatment used when a tumour depends on hormones or hormone-related signalling for growth. It is most commonly used for hormone receptor-positive breast cancer and prostate cancer, and it also has a role in selected gynaecological and other hormone-sensitive cancers. Unlike chemotherapy, endocrine treatment does not primarily work by damaging rapidly dividing cells. Instead, it reduces hormone production, blocks hormone receptors or interferes with the signals that hormones use to stimulate cancer cells.
Northern Blood & Cancer Care provides specialist hormone therapy planning and long-term oncology follow-up for patients across Melbourne. Because endocrine treatment may continue for months or years, the focus is not only on cancer control but also on maintaining bone health, muscle strength, cardiovascular and metabolic health, sexual wellbeing and day-to-day quality of life. Our oncologists work with hospital services and can coordinate referrals to appropriate external health professionals to support these longer-term needs.
Some cancer cells carry receptors that allow hormones to stimulate their growth. In breast cancer, oestrogen and progesterone receptors are routinely assessed on pathology. In prostate cancer, cancer cells are often driven by androgen signalling, particularly testosterone. Endocrine therapy interrupts these pathways so the cancer receives less of the growth signal it depends on.
Cancer hormone therapy is not the same as hormone replacement therapy. Hormone replacement is used to replace hormones that the body no longer makes adequately, whereas endocrine cancer treatment generally aims to block or reduce hormone signalling. The exact approach depends on the cancer type, whether the disease is localised or advanced, the patient’s age and hormonal status, previous treatments and other medical conditions.
Endocrine therapy is a central treatment for breast cancers that express oestrogen and/or progesterone receptors. It may be used after surgery to reduce the risk of recurrence, before surgery in selected situations, or to control metastatic disease. The treatment chosen depends on whether a patient is premenopausal or postmenopausal, the recurrence risk, previous therapy and tolerance. In some higher-risk or advanced cancers, endocrine therapy is combined with a targeted medicine.
Side effects reflect the hormone pathway being suppressed and vary between breast and prostate cancer treatments. Common issues can include hot flushes, sweats, fatigue, sleep disturbance, sexual changes, reduced libido, vaginal symptoms or erectile difficulties. Some breast cancer endocrine treatments can cause joint and muscle symptoms, while androgen deprivation for prostate cancer can contribute to loss of muscle mass, increased body fat and reduced physical capacity.
Bone health is an important consideration because prolonged reduction of oestrogen or testosterone can accelerate bone loss. Depending on the treatment and individual risk factors, the oncologist may recommend a baseline bone-density scan, repeat monitoring, attention to calcium and vitamin D intake, weight-bearing exercise and, in selected patients, bone-protective treatment.
Metabolic and cardiovascular health also matters, particularly during long-term androgen deprivation. Blood pressure, cholesterol, glucose, body composition and existing cardiovascular disease may influence monitoring. Some endocrine therapies have additional class-specific risks, so patients receive advice tailored to the exact medicine rather than a generic list.
Follow-up usually includes review of side effects, adherence and signs of cancer recurrence or progression. The tests used depend on the cancer. Breast cancer follow-up may include routine clinical review and breast imaging where appropriate, while prostate cancer monitoring often includes PSA and other blood tests. In advanced disease, imaging is arranged according to symptoms, tumour markers and the treatment pathway.
Exercise is one of the most practical supportive strategies for many people receiving long-term endocrine treatment. Accredited exercise physiology can help maintain muscle strength, bone loading, cardiovascular fitness and function, and can be particularly valuable for men receiving androgen-deprivation therapy. Referral to an accredited exercise physiologist may therefore be recommended when this would support the patient’s treatment and long-term health.
Patients should also raise sexual health, menopausal symptoms, fertility, mood changes and sleep problems. These can have a major effect on quality of life and are legitimate parts of cancer care. Management may involve the oncology team, GP or other specialists depending on the issue.
Northern Blood & Cancer Care has strong expertise in the cancers where endocrine treatment is most important. The team combines longstanding breast and genitourinary oncology experience with clinical-trial involvement and broad solid-tumour practice.
This breadth allows endocrine therapy to be considered alongside surgery, radiotherapy, chemotherapy, targeted therapy and clinical trials rather than as a treatment in isolation. Patients can consult at Northern Private Hospital in Epping, with hospital treatment and multidisciplinary links coordinated through Northern Private Hospital, Northern Health and other Melbourne services as clinically appropriate.
Please bring a current referral, medication list, pathology and imaging reports and details of previous cancer treatment. For breast cancer, receptor status and HER2 results are particularly relevant. For prostate cancer, PSA trends, pathology and staging imaging help guide the discussion. Your specialist will explain why endocrine therapy is recommended, the expected duration, how benefit is monitored and which side effects are most relevant to the treatment being considered.
If you already take hormone-related medicines, have osteoporosis, previous fractures, cardiovascular disease, diabetes or significant sexual-health concerns, mention these during the consultation because they may influence monitoring and supportive care.
Hormone therapy can be highly effective, but its benefits often depend on staying well enough to continue treatment over months or years. Northern Blood & Cancer Care combines dedicated breast and prostate oncology expertise with attention to bone health, metabolic health, sexual wellbeing and exercise, helping patients manage both the cancer and the longer-term effects of treatment.
Northern Blood & Cancer Care brings together a highly experienced team of haematologists, medical oncologists and specialist physicians, with consultations available at Northern Private Hospital in Epping.
Contact our team to arrange an appointment or discuss a referral.
